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Polymorphism of Human Platelet Membrane Glycoprotein IIb Associated With the
Bak"/Bakb Alloantigen System By Suzanne Lyman, Richard H. Aster, Gian P. Visentin, and Peter J. Newman
The human Bak"/Bakb alloantigen system has been implicated in the pathogenesis of post-transfusion purpura and neonatal alloimmune thrombocytopenic purpura. Human alloantisera specific for either the Bak' or Bakb allele have been shown t o react exclusively with the heavy chain of membrane glycoprotein (GP) Ilb. To investigate the structure of the Bak epitopes, we used the polymerase chain reaction (PCR) t o amplify GPllb cDNA synthesized from platelet RNA samples prepared from individuals of known serologic phenotype. Subsequent DNA sequence analysis of amplified GPllb cDNAs derived from one Bak' homozygous individual and one Bakb homozygous individual revealed a single nucleotide base difference near the 3' end of the mRNA encoding the GPllb hefivy chain. Short 13 base allele-specific oligonucleotides (ASO) containing the putative phenotype-specific base in the middle were then synthesized, end-labeled with digoxigenin-1 1 -dUTP using
LATELET MEMBRANE glycoproteins bear serologi-P cally defined determinants that can elicit an alloimmune response leading to platelet destruction in such clinical settings as post-transfusion purpura (PTP) and neonatal alloimmune thrombocytopenia (NATP).' These well-characterized syndromes are associated with the development of platelet-reactive alloantibodies as a result of platelet incompatibility in blood transfusion recipients (PTP) and in maternal sensitization to paternal antigens on fetal platelets (NATP).' While the incidence of PTP is not precisely known, the incidence of NATP has been estimated to be as high as 1 in 2,000 live birth^,^ and delivery can result in significant morbidity and mortality to the n e~b o r n .~~' Nine different platelet alloantigen systems have thus far been described. The PlA'/PlA2 antigen system, located on membrane glycoprotein (GP) IIIa, is perhaps the most important clinically, accounting for a majority of reported cases of PTP and NATP. However, other antigen systems have clearly been implicated in these two immune disorders as well. These include, in order of clinical significance, the Bak"/Bakb system that has been localized to the heavy chain of GPIIb,6.7 the recently described Bra/Brb alloantigen system that has been localized to the GPIa/IIa c0mplex,8.~ the Pen," alternatively known as Yuk," alloantigen system, located on GPIIIa," and the PIE antigen, which has been localized to the heavy chain of G P 1b.l3
The Bak antigen system was first described in 1980 by von dem Borne et a1 when they reported a new specificity present in a maternal alloantibody in a case of NATP.6 Subsequently, an antibody termed anti-Leka was described by Boizard and Wautier,I4 and the antigenic determinant for this antibody was localized to 76 and 60 Kd fragments of the heavy chain of GPIIb." Shortly thereafter, the Bak" antigen was also localized to GPIIb,' and the Baka and Lek" antigens were shown to be identical.l6-" The first characterization of the allele for Bak", Bakb, was published only recently," and it too was localized to the heavy chain of GPIIb. Interestingly, Letellier et a1 predicted, on the basis of family studies, a close genetic linkage between the P I A and Bak alloantigen terminal transferase, and used as probes in subsequent dot-blot hybridization experiments. Platelet RNA was prepared from a panel made up of four Bak"", three BakbIb, and t w o BakaIb individuals, and the mRNA encoding GPllb was amplified using PCR and spotted onto nylon membranes. AS0 hybridization showed that the nucleotide base difference identified above segregated with Bak phenotype in all nine individuals examined ( P = .002). The base pair substitution results in an amino acid polymorphism at residue 843 of the mature heavy chain. The Bak" form of GPllb encodes an isoleucine at this position, whereas the Bakb allele contains a serine. Identification of the polymorphism associated with this clinically important alloantigen system should permit new therapeutic and diagnostic approaches for treating and managing patients with alloimmune thrombocytopenic disorders. systems," and these predictions appear to have been borne out by more recent physical mapping studies using pulse-field gel electrophoresisz0
Recent developments have now made it possible to examine the molecular basis of the Bak"/Bakb alloantigen system. First, the nucleotide sequence of GPIIb has been fully determined." Subsequently, it was reported that the polymerase chain reaction (PCR) could be adapted for the amplification and subsequent analysis of platelet-specific mRNA sequences from single individuals. 22 We have recently used this approach to elucidate the molecular nature of the PIA' and PIA' p~l y m o r p h i s m .~~ In this report, we provide evidence that a single base difference at nucleotide position 2622 of GPIIb mRNA is associated with the Baka/Bakb alloantigen system. This base change results in an isoleucine/serine polymorphism at amino acid 843 near the C-terminus of the GPIIb heavy chain.
MATERIALS AND METHODS
Platelet RNA from a panel of nine unrelated normal volunteers, including four BakaIa, three BakbIb, and two Barib individuals, was prepared according to the procedure of Chomczynski and SacchiZ4 except that the final RNA pellet was use only.
For personal at PENN STATE UNIVERSITY on February 20, 2013. bloodjournal.hematologylibrary.org From subjected to one additional phenol/chloroform extraction and ethanol precipitation necessary to achieve reproducible gene amplification of platelet cDNA. Bak" and Bakb phenotype was assessed using well-characterized human alloantisera in a standard antigen capture a s~a y . '~. '~ The C-terminal end of the GPIIb heavy and light chain message from base 1988 to 2821 was selected for sequence analysis and comparison, and two 24-base oligonucleotide primers flanking 833 base pairs of this region were synthesized on a Gene Assembler (Pharmacia Fine Chemicals, Piscataway, NJ). The antisense primer (5'-CAGGAAGGCCAGCACCGTGACCATG-3') from base 2821 to 2797 was used to prime the synthesis of cDNA from platelet RNA, as previously d e~c r i b e d .~~,~, The second strand was generated by the sense primer (5'-GACCTGCAGATGGACGCAGCCAAC-3') from base 1988 to 2011 during the first round of PCR. Amplification was carried out in a DNA Thermal Cycler (PerkinElmer Cetus, Norwalk, CT) programmed to permit denaturation at 94°C for 1 l/2 minutes, annealing at 50°C for 1 ]/2 minutes, and chain extension at 72°C for 3 minutes. The reaction was allowed to proceed for 30 cycles, followed by a final incubation at 72°C for 7 minutes to allow completion of strand synthesis.
PCR samples were analyzed on 1.8% Seakem GTG agarose gels (FMC BioProducts, Rockland, ME), and the appropriate bands were excised and recovered by electroelution. The plasmid vector pCEM-SZf (Promega Biotech, Madison, WI) was prepared for ligation by restriction digestion with EcoRV (New England Biolabs, Beverly, MA) to yield blunt ends, and ligated to purified amplification products, followed by transformation into Escherichia coli strain NM522 competent cells (Stratagene Cloning Systems, San Diego, CA). Two clones representing each Bak homozygous phenotype were selected for direct sequence analysis by the dideoxy sequencing method using T7 DNA polymerase (USB, Cleveland, OH). Four 24 to 25 base oligonucleotides corresponding to internal GPIIb cDNA sequences were synthesized and used as sequencing primers.
Allele-specific hybridization. Amplified cDNA from four individuals with Bak"/" phenotype, three with BakbIb, and two heterozygous for Bak was subjected to hybridization with 13-base allelespecific oligonucleotides (ASO). Probe A (TGCCCATCCCCAG) corresponds to the published sequence from base 2616 to 2628, and probe B (TGCCCAGCCCCAG) differs only in the middle base, a G instead of a T, and corresponds to a single base difference observed in the region sequenced. The oligos (200 ng) were end-labeled with digoxigenin-1 1-dUTP (Boehringer Mannheim, Indianapolis, IN) in 25 pL 100 mmol/L potassium cacodylate, 2 mmol/L CoCl,, 0.2 mmol/L DTT, pH 7.2 containing 1 U terminal transferase (Boehringer Mannheim), and the probes were used for hybridization without purification. Amplified DNA was used directly for blotting, or, in some cases, appropriate bands were recovered from agarose gels using Gene Clean (Bio 101, La Jolla, CA). The samples were eluted in 20 pL water, diluted 1/10,000, and 10 pL was used for reamplification using the same oligos and PCR conditions. Amplified or reamplified DNA was denatured in 0.25 N NaOH, 1.5 mol/L NaCl at room temperature for 5 minutes, followed by neutralization in 2 mol/L NaCI, 1.3 mol/L Tris, pH 7.4 at room temperature for 15 minutes. Each sample was divided between two wells of a Minifold dot blot apparatus (Schleicher and Schuell, Keene, NH) and transferred to Magnagraph nylon membrane (MSI, Westboro, MA) by vacuum suction. The filter was exposed to UV irradiation (Fotodyne, New Berlin, WI) for 5 minutes, followed by baking at 8OoC for 15 minutes. The membrane was prehybridized in 5x Denhardt's, 5x standard sodium citrate (SSC), 5 mmol/L EDTA, I O mmol/L Na2HP04, pH 7.0 at 68°C for 1 hour and then cut into two strips that were hybridized to either probe A or probe B in 4 mL l o x Denhardt's, 5 x SSC, 5 mmol/L EDTA, 7% sodium dodecyl sulfate (SDS), SOpg/mL salmon sperm DNA, 20 mmol/L Na2HP04, Analysis of PCR products. pH 7.0 at 42°C overnight. The filters were washed in two changes of 6 x SSC for 30 minutes each at room temperature, followed by two changes of 3 mol/L tetramethylammonium chloride (Aldrich Chemical, Milwaukee, WI), 2 mmol/L EDTA, 1% SDS, 50 mmol/L Tris, pH 8.0 for 20 minutes each at 42°C. Positive hybridizations were visualized using the Genius kit (Boehringer Mannheim, Indianapolis, IN), which uses an alkaline phosphatase-conjugated antidigoxigenin antibody.
Platelets were washed in Ringer's citrate dextrose buffer (RCD:IO8 mmol/L NaCI, 38 mmol/L KCI, 1.7 mmol/L NaHCO,, 21.2 mmol/L Na citrate, 27.8 mmol/L dextrose, 1.1 mmol/L MgCI,, 2 mmol/L EDTA, and 50 ng/mL PGE,, pH 6.5
, La Jolla, CA) diluted to 1 to 5 pg/mL in RCD buffer, and incubated for 1 hour at room temperature. After three washes, Bak-labeled cells were incubated with affinity purified F(ab'), fragments of fluorescein isothiocyanate (FITC)-conjugated goat anti-human IgG (Jackson Immunoresearch, West Grove, PA), and PMI-1-labeled cells were incubated with affinity purified F(ab')2 fragments of R-phycoerythrin (rPH)-conjugated goat anti-mouse IgG (Tago Immunological, Burlingame, CA) for 30 minutes at room temperature. Labeled cells were washed three times and subjected to flow analysis. To assess potential competition between PMI-1 and anti-Bakb antibodies, platelets were incubated with anti-Bakb at a 1:25 dilution (95% saturation) in the presence of PMI-1 at 5 pg/mL, which was in excess of saturation. The converse experiment was also done, in which platelets were incubated with PMI-1 at 1 pg/mL (90% of saturation) in the presence of anti-Bakb diluted to l:lO, which was in excess of saturation. Preliminary studies were done to show that FITC-goatanti-human IgG did not crossreact with mouse IgG, and rPH-goatanti-mouse IgG did not crossreact with human IgG (data not shown). The samples were analyzed on a FACStarp'"' Fluorescence Activated Cell Sorter (Becton Dickinson, Mountain View, CA) using an argon laser source at 488 nm. Fluorescein and rPhycoerythrin were detected through a 530+ / -30 nm band-pass filter, and 10,000 events were acquired per sample.
Flow cytometric analysis.

RESULTS
Amplijcation and analysis of the C-terminal region of
GPIIb platelet mRNA. T o compare the nucleotide sequence of GPIIb m R N A derived from one Bak" and one Bakb homozygous individual, four different pairs of oligonucleotide primers were designed such that overlapping segments of the molecule could be sequentially amplified and their sequence determined. Nucleotide sequence analysis of a n 833 base pair region positioned near the 3' end of G P I I b c D N A (Fig 1) revealed a single nucleotide difference a t base 2622 of the GPIIb m R N A (Fig 2) . T h e Bak"'" individual has a T a t this position, whereas the Bakb/b individual has a G.
This results in the substitution of a serine for a n isoleucine at amino acid residue 843 of the G P I I b heavy chain.
Correlation of Ne,,, t--* Ser,,, polymorphism with Bak allotype. In order to determine whether the T c* G polymorphism was associated with Bak phenotype, as opposed to a Taq polymerase error or a naturally occurring polymorphism unrelated to Bak phenotype, platelet R N A was prepared from a total of nine unrelated individuals of known Bak phenotype, and then amplified using P C R to use only. yield the same 833 bp product. We then performed allelespecific hybridization analysis, using two 13-base probes containing the putative phenotype-specific base in the middle, toscreen the amplified cDNAs. Allele-specific oligonucleotides will hybridize to the exact complementary sequence; however. a single base mismatch will prevent annealing of the probe at a specified temperature that is dependent on the length of the probe.I6 As shown in Fig 3, probe A (containing a T in the middle) was positive with the four Bak"' homozygous individuals, and probe B (containing a G in the middle) was positive with three BakbIb individuals, whereas both oligonucleotides hybridized with amplified cDNA derived from the two heterozygous individuals. Thus, all nine individuals examined by DNA typing. representing the three possible Bak phenotypes, yielded the genotypes expected (P = .002) Based upon these results, wc conclude that the observed base change is directly associated with the Bak'/ Bakb alloantigen system.
Physical relationship of the Bok and PMI-I epitopes.
Comparison of the location of the Bak polymorphism to the amino acid sequence of GPllb (Fig 4) revealed that this 
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amino acid is just outside of a 17-residue sequence that contains the epitope for the anti-GPllb murine monoclonal antibody, PMI-I." To explore the physical relationship between these two epitopes, a series of competitive binding studies were done. In one set of experiments, PMI-I was present in limiting concentrations (approximately 904% of saturation). while anti-Bakb was in excess. The converse experiments. in which anti-Bakb was present in limiting amounts (95% saturation) and PMI-I was present in excess.
were also done. Platelets containing one or both sets of antibodies in various ratios were analyzed by flow cytometry, and the results are shown in Fig 5. As can be seen, no competition between the two antibodies was observed, despite their apparent physical proximity.
DISCUSSION
The purpose of the present study was to determine the molecular basis for the Bak'/Bakb polymorphism of platelet membrane GPllb. Based on the reported nucleotide sequence of GPllb derived from HEL cells, we designed oligonucleotide primers and used the PCR to amplify an 833 base pair C-terminal region of GPllb from both a Bak' homozygous and a Bakb homozygous individual. The sequence of the Bak' individual proved to be identical with the published sequence of GPllb, except for a single nucleotide difference at base 2622 in the sequence from the Bakb individual. The substitution of a G for a T at this position resulted in an isoleucine * serine polymorphism at amino acid 843 of the GPllb heavy chain.
GPllb is composed of a 125 Kd heavy chain that is disulfide-linked to a 23 Kd light chain.B Earlier studies of the biosynthesis and processing of GPIlbn"' provide evidence that a single mRNA transcript is used to synthesize a precursor of GPllb that is cleaved post-translationally to yield the two disulfide-linked chains, and these studies were substantiated by the recent molecular cloning of GPllb cDNA.*' Hydropathicity analysis of the cDNA sequence indicates that GPllb is anchored to the platelet through a single transmembrane domain located within 20 amino acids of the C-terminus of the light chain. The studies reported here localize the amino acid difference associated with the Bak polymorphism near the C-terminus of the heavy chain within a proline-rich region.
Further studies are needed to elucidate the exact nature of the epitope recognized by Bak alloantisera. Although it is most likely that these two polymorphic amino acids are responsible for directing the formation of the Bak antigenic determinants, differences in carbohydrate moieties could also play a role in antigenicity. Since the amino acid substitution in Bak involves a serine, it is possible that an 0-linked carbohydrate could be added to the Bakb molecule. Another possibility that must be considered is that the Ile -Ser amino acid difference causes a conformational change on some other portion of the molecule that forms the actual epitope. Finally, our findings do not preclude the possibility of other polymorphisms in the GPllb gene that may be associated with Bak phenotype.
It is of considerable interest that the Bak polymorphism is immediately adjacent to the 17-amino acid residue region containing the epitope recognized by the monoclonal antibody PMI-I." Functional studies using the PMI-I antibody have previously shown that this region may be involved in platelet adhesion to collagen.32 The effect of anti-Bak alloantisera on platelet/collagen interactions has not been examined to date, nor have the possible consequences of anti-Bak antibodies on in vivo platelet function in alloimmunized patients been considered. In order to explore the possible relationship of these two epitopes, we did cross-blocking studies using PMI-1 and anti-Bakb. Somewhat surprisingly, our data indicate that there is no competition for binding of these two antibodies. Secondary structure analysis of GPIIb33 indicates that the sequence KRDRRQ, located a t the C-terminal third of the peptide to which PMI-1 binds, is the second most likely antigenic site on this molecule. If this sequence serves as the epitope for PMI-1, then there would be 11 amino acid residues between this epitope and the likely Bak antigenic determinant. The proline-rich nature of this region and its predicted highly convoluted secondary structure may explain the co-occupation of adjacent sites by these two antibodies.
In addition to its inhibition of platelet-collagen interactions, PMI-1 has also been shown to bind preferentially to the GPIIb-IIIa complex after its occupation with either fibrinogen or the Arg-Gly-Asp tripeptide sequence; consequently, the PMI-1 epitope has been referred to as a ligand-induced binding site, or LIBS. 34 Given the close association between the BAK and PMI-1 epitopes, it is interesting to note that anti-Bak" antibodies were found to bind to only 20,000 sites per platelet at ~aturation,'~ even though 40,000 GPIIb-IIIa complexes are surface exposed.36 It is tempting to speculate that the Bak alloantigen may represent another example of an occupancy-modulated region of the platelet fibrinogen receptor.
Increasingly, molecular techniques are being used to define sequence variations responsible for inherited genetic disorders and naturally occurring polymorphisms. While two human platelet alloantigen systems, Bak and PIA, have now been examined at the molecular level, it will be important to delineate the molecular basis of additional platelet membrane polymorphisms in order to achieve a better understanding of platelet membrane glycoprotein fine structure responsible for generating an alloimmune response. Knowledge of the amino acids responsible for directing the formation of these polymorphic determinants may lead to the development of more refined immunodiagnostic assays, for example, allotype-specific monoclonal antisera. Our findings also provide an alternative to immunologic-based assays, as DNA typing using allele-specific oligonucleotide hybridization is able to discriminate between Bak"', and Bakb/b individuals with a high degree of precision and reliability.
DNA-based techniques can readily be adapted to establish diagnostic tests in the transplant or transfusion setting, as well as cases requiring in utero diagnosis, and may offer several important advantages over present serologic methods of phenotyping that rely on a limited supply of alloantisera.
